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Abstract
Major trauma induces marked metabolic changes which contribute to the systemic immune
suppression in severely injured patients and increase the risk of infection and posttraumatic organ
failure. The hypercatabolic state of polytrauma patients must be recognized early and treated by an
appropriate nutritional management in order to avoid late complications. Clinical studies in recent
years have supported the concept of "immunonutrition" for severely injured patients, which takes
into account the supplementation of Ω-3 fatty acids and essential aminoacids, such as glutamine.
Yet many aspects of the nutritional strategies for polytrauma patients remain controversial,
including the exact timing, caloric and protein amount of nutrition, choice of enteral versus
parenteral route, and duration. The present review will provide an outline of the pathophysiological
metabolic changes after major trauma that endorse the current basis for early immunonutrition of
polytrauma patients.
Introduction
Severe trauma induces massive changes of the physiologi-
cal state by alteration of metabolic pathways and activa-
tion of the innate immune system [1-5]. The
posttraumatic metabolic changes are characterized by
hypermetabolism with increased energy expenditure,
enhanced protein catabolism, insulin resistance associ-
ated with hyperglycemia, failure to tolerate glucose load,
and high plasma insulin levels ("traumatic diabetes")
[1,2,6-11]. The alterations of the physiological metabolic
pathways leads to the development of hyperglycemia and
metabolic acidosis with hyperlactatemia [10,12]. The
increased oxygen demands of the polytraumatized patient
further aggravate the hypermetabolic state by enhanced
mitochondrial oxygen utilization [1,10,13,14].
Metabolic changes after trauma were described more than
six decades ago by Cuthbertson (Lancet 1942, 1:433–437)
and characterized as occurring in two different phases,
termed the "ebb" phase and the "flow" phase (table 1). The
"ebb" phase is initiated within minutes after trauma and
persists for several hours after the initial insult. It is char-
acterized by a decline in body temperature and oxygen
consumption, aimed at reducing posttraumatic energy
depletion. However, the brief duration of this phase limits
its clinical relevance. The "flow" phase, which occurs after
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compensation of the state of traumatic-hemorrhagic
shock, is associated with an increased metabolic turnover,
activation of the innate immune system and induction of
the hepatic acute-phase response [2,3]. This results in an
increase of the catabolic state with a significantly
increased consumption of energy and oxygen
[2,10,13,14]. The amount of oxygen consumption and
demand in patients with traumatic-hemorrhagic shock
can be calculated using a formula described by Nunn and
Freeman in 1964 (table 2) [15].
In addition to the acute hypermetabolic state, the systemic
inflammatory cascade is initiated as a consequence of
trauma, as characterized by the release of pro-inflamma-
tory cytokines and activation of the complement system
[4,5,16,17]. The bacterial translocation caused by the
traumatic-hemorrhagic shock may further aggravate these
metabolic sequelae and inflammatory response [5,10,17-
19], but this issue remains controversial [20]. Addition-
ally, the frequent use of vasoactive drug therapy for hemo-
dynamic resuscitation in traumatic-hemorrhagic shock
has a profound impact on metabolism and organ energy
status of the injured patient [1,10]. Most severely injured
patients require inotropic support to promote hemody-
namic stability. For example dopamine, a commonly used
epinephrine precursor, leads to depression of pituitary
function and inhibition of prolactin and growth hormone
production [21]. Thus, the use of vasoactive drugs further
promotes catabolism by reducing serum levels of anabolic
hormones. In contrast, endogenous catecholamines, cor-
tisol and glucagon levels are highly elevated after trauma,
leading to increased energy substrate mobilization [3,6].
Interestingly, studies in severe burn patients have shown
that exogenous insulin administration can attentuate pro-
tein catabolism as indicated by an increase in protein syn-
thesis [11,22,23]. Proteinolysis of skeletal muscle and
glycolysis are increased with the aim to provide the sub-
strates for the hepatic gluconeogenesis and the hepatic
biosynthesis of acute-phase proteins [2,24]. The meta-
bolic state is reoriented towards supporting the organ-
ism's immune response and wound healing at the cost of
enhanced proteinolysis of skeletal muscle [1,2]. In addi-
tion, the physical and psychological stimulation of the
neuroendocrine axis through fear, stress, pain, inflamma-
tion and shock increases the caloric turnover significantly
above the baseline situation in healthy individuals [6,10].
This leads to increased serum levels of catabolic hor-
mones, such as cortisol, glucagon and catecholamines,
and decreased levels of insulin causing the posttraumatic
catabolic diabetic phase [10,11,25]. In contrast, the phe-
nomenon of "occult adrenal insufficiency" has been dem-
onstrated to occur in severely injured patients in the ICU,
as defined by a serum cortisol below 18 mg/dL [26] or
below 25 mg/dL [27] in different publications. However,
up to present the clinical implication of posttraumatic
adrenal failure with regard to patient outcome remains
controversial [26-29].
Depending on the severity of the initial injury and the
quality of the therapeutic regimen for the polytrauma-
tized patients, catabolic changes in posttraumatic metab-
olism can last for several days or weeks [3].
Metabolic control and immunonutrition
The state of hypercatabolism after severe injury can lead to
severe complications associated with posttraumatic
hyperglycemia, hypoproteinemia, lactate acidosis, and
immunosuppression [2,8,10]. Thus, the presence and sig-
nificance of these metabolic alterations must be recog-
nized and appreciated in severely injured patients. An
optimal therapeutic regimen should include the concept
of a "metabolic control" in addition to the initial meas-
ures of resuscitation by hemorrhage control and securing
airways and oxygenation [2,30,31]. The posttraumatic cat-
abolic state requires an adjusted energetic balance with
early protein substitution and hypercaloric nutrition
[2,8,30,31]. Patients with major injuries who receive no
nutrition during the first few days after trauma can
develop cumulative caloric and protein deficits which
contribute to the risk of increased complications, such as
infections and organ failure [2,8,32]. Consequently, clin-
ical pathways and algorithms for nutritional support of
Table 1: Metabolic changes after major trauma.
"Ebb" phase (hours) "Flow" phase (days to weeks)
Decreased body temperature Increased body temperature
Decreased oxygen consumption Increased oxygen consumption
Lactate acidosis Negative nitrogen balance
Increased stress hormone levels Increased stress hormone levels
Decreased insulin levels Normal to increased insulin levels
Hyperglycaemia, insulin resistance Hyperglycaemia, insulin resistance
Gluconeogenesis Gluconeogenesis
Increased substrate consumption Proteinolysis ("autocannibalism")
Hepatic acute-phase response Lipolysis
Immune activation Immunosuppression
Table 2: Calculation of available oxygen (O2av in ml/min) in bleeding polytrauma patients according to the formula described by Nunn 
and Freeman in 1964 [15].
O2av = CO × SaO2 × Hb × 1.34
[CO, cardiac output (ml/min); SaO2, arterial oxygen saturation (%); Hb, hemoglobin concentration (g%); 1.34, O2 binding capacity constant (ml O2/g 
Hb)].World Journal of Emergency Surgery 2006, 1:29 http://www.wjes.org/content/1/1/29
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severely injured patients during the intensive care period
have been developed in recent years [8,10,12,30,31,33].
These protocols are designed to restore the capacity for
optimal immune and inflammatory responses and to
facilitate the recovery and healing from trauma and subse-
quent infections. Early enteral nutrition has been advo-
cated as the concept of choice for nutrition of
polytraumatized and severely ill patients. In this regard,
prospective randomized controlled trials have clearly
demonstrated the positive effect of an early full enteral
nutrition with a decreased posttraumatic infection rate, a
shorter duration of hospital stay, and an improved overall
outcome [32,34-42].
The specialized nutritional support for severely injured
patients includes the administration of "immune nutrient
cocktails" which have been shown to improve the survival
of septic patients during the intensive care period [33,43].
The concept of "immunonutrition" has been established
in recent years and exemplified by the enteral supplemen-
tation of glutamine, one of the most promising new nutri-
tional concepts for severely injured patients in recent years
[32,37,44-47]. Glutamine is an essential aminoacid
which exerts metabolic benefits beyond its nutritional
value by mediating immunological effects, such as induc-
tion of neutrophil phagocytic activity and oxidative burst
[32,48,49]. Glutamine was also shown to protect neu-
trophils from undergoing apoptosis in vivo [50]. In addi-
tion, glutamine is a precursor to the reducing agent
glutathione and thus contributes to antioxidant effects
and cellular protection from ischemia/reperfusion-medi-
ated injury [45,51]. This protective effect of glutamine has
been demonstrated in different experimental models of
ischemia/reperfusion injury [52,53]. Also, models of
experimental starvation have shown the important nutri-
tional effect of glutamine for enterocytes and intestinal
mucosa [8]. Furthermore, glutamine has been shown to
restore cellular energy reserves to normal levels after hem-
orrhagic shock and to attenuate the extent of shock-
induced cellular apoptosis [54]. This finding is supported
by reduced bacterial translocation in rat guts and
improved gut immune function after diet supplementa-
tion with glutamine [45]. A prospective, randomized,
double-blind controlled clinical trial demonstrated that
glutamine supplementation reduces the incidence of mul-
tiple organ failure and death attributed to infections in
critically ill patients [32]. In addition to glutamine, Ω-3
fatty acids have become an important nutritional supple-
mentation for severely injured patients in recent years [55-
57]. These long-chain polyunsaturated fatty acids derived
from fish oil were shown to exert potent anti-inflamma-
tory properties in trauma patients, such as attenuation of
arachidonic acid-derived metabolites like prostaglandin
PGE2 and leukotriene LTB4, inhibition of leukocyte activa-
tion and chemotaxis, and attenuation of pro-inflamma-
tory gene expression levels [39,57-59].
Other nutritional supplements that promote anabolism
in trauma patients include phospholipids, leptins, and
anabolic hormones, such as thyroid hormones, growth
hormone, and insulin [8,22,23,60,61]. For example,
growth hormone substitution has been shown to promote
protein anabolism in severely injured patients [62].
Recently published consensus guidelines based on meta-
analyses from multiple prospective trials have helped clar-
ify the indication for supplementation of specific nutri-
ents in the clinical setting [31,44,63-65]. Moreover, the
use of vasoactive therapy has been shown to influence not
only the systemic and regional perfusion and organ blood
flow, but also to affect the balance between oxygen and
substrate supply [66]. The use and necessity of exogenous
catecholamines should therefore be well calculated and
balanced against the potential adverse influence on meta-
bolic needs during the catabolic phase of critically ill
trauma patients. Furthermore, there is evolving evidence
that over-resuscitation, i.e. driving oxygen delivery to sup-
raphysiological levels, may be deleterious [67].
Clinical implications for severely injured patients
Although several studies have shown the positive effect of
immunonutrition, its clinical impact remains debated,
and the benefit may be specific to certain patient popula-
tions [68-70]. Despite this lack of consensus, the concept
of early enteral feeding is generally accepted among
trauma surgeons and intensive care physicians [32,34-42].
More than a decade ago, Moore and colleagues demon-
strated in prospective randomized trials on patients with
abdominal injuries [71] the positive effect of early enteral
nutrition with a significant reduction of intraabdominal
and pulmonary infections [34-36,72]. When compared to
total parenteral nutrition, the enteral route is associated
with a significantly decreased incidence of septic compli-
cations [39]. Although anecdotal reports have been pub-
lished on the adverse effects and complications of enteral
feeding procedures in critically ill patients [73], the overall
consensus in the literature clearly advocates for the posi-
tive effects of early enteral nutrition in severely injured
patients [31,42,43,68,72,74,75]. An issue under debate in
clinical practice is the question of when early immunonu-
trition should be initiated [65]. This question has not
been fully adressed in the current literature and requires
further analysis with future clinical trials [76].
In daily clinical practice, the individual caloric require-
ment for severely injured patients should be assessed with
defined algorithms, tables and equations. For example,
the method of indirect calorimetry by the Weir equation
helps to assess the energy expenditure by the parametersWorld Journal of Emergency Surgery 2006, 1:29 http://www.wjes.org/content/1/1/29
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oxygen consumption and carbon dioxide production
[7,77]. The basic metabolic rate can be calculated by the
Harris-Benedict equation using the standard variables of
height, weight, age and gender [7,78]. However, it is of
key importance not to "overfeed" critically injured
patients with calories, since this may contribute to adverse
outcome [1,39,79,80]. Early overfeeding of severely
injured patients leads to an increase in overall oxygen con-
sumption, carbon dioxide production, hepatic lipogene-
sis, and hyperglycemia, and thus contributes to secondary
immune suppression during the ICU phase [80]. Obese
patients are particularly susceptible to the adverse effects
of overfeeding. Therefore, a hypocaloric (<20 kcal/kg/
day), high-protein nutrition was postulated as a safe pro-
tocol for critically injured obese patients and shown to be
as effective as eucaloric or hypercaloric feeding (>20 kcal/
kg/day) in this specific patient group [81-83]. Current
feeding recommendations for morbidly obese ICU
patients are about 20 kcal and 2 g of protein per kg ideal
body weight per day [83].
The standard daily doses of protein, glucose, fat and
amino acid concentrations must be clearly defined and
adjusted to the calculated individual patients metabolic
needs [77-80,83,84]. An example of a standardized
enteral nutrition is Impact®; one of the most commonly
used clinical formulas. Multicenter prospective rand-
omized clinical trials on critically ill trauma patients have
demonstrated that the administration of Impact® for 7 to
10 days reduced the rates of infection, wound complica-
tions, and the risk of multiple organ failure [36,72,75].
Nonetheless, standardized enteral nutrition is not consist-
ently administered to critically ill trauma patients. Inter-
national clinical guidelines for nutritional support in
critically ill patients have been published by the American
Society of Parenteral and Enteral Nutrition (ASPEN), the
Canadian Society for Clinical Nutrition and more recently
the  European Society of Parenteral and Enteral Nutrition
(ESPEN) [76,85,86].
A review by Wernerman provides a detailed analysis of the
weaknesses and strengths of the respective recommenda-
tions for nutritional support of critically ill patients [87].
Altogether, the guidelines clearly favor the concept of
early enteral nutrition within 24–48 hours after admis-
sion in the intensive care unit [87]. For daily use in clinical
practice, the reader is referred to the published clinical
guidelines for nutritional support [39,76,85,86]. The
main recommendations derived from the ESPEN guide-
lines are summarized in table 3. Furthermore, our own
institutional protocol for nutritional support of severely
injured patients is shown in figure 1. The clinical value of
these guidelines is awaiting scientific validation by imple-
mentation in future prospective randomized trials.
Conclusion
Dramatic metabolic changes occur in severely injured
patients which must be acknowledged early and moni-
tored during the posttraumatic phase. Appropriate immu-
nonutrition should be started in the ICU, preferably by
enteral route, in order to counteract the potentially devas-
tating effects of the massive hypermetabolic state after
Table 3: Summary of the main recommendations from the ESPEN guidelines for enteral nutrition of critically ill patients. Adapted 
from: [76].
Recommendations
Indications and application 
of enteral nutrition (EN)
All patients who are not expected to be on a full oral diet within three days.
The expert committee recommends that haemodynamically stable critically ill patients who have a functioning 
gastrointestinal tract should be fed early (<24 h) using an appropriate amount of nutrition.
Exogenous energy supply (kcal):
• 20–25 kcal/kg body weight/day during the acute and initial phase of critical illness.
• 25–30 kcal/kg body weight/day during the anabolic recovery phase,
Consider parenteral administration of metoclopramide or erythromycin in patients with intolerance to enteral 
feeding (e.g. with high gastric residuals).
Route of administration Use EN in all patients who can be fed via the enteral route.
There is no significant difference in the efficacy of jejunal versus gastric feeding in critically ill patients.
Avoid additional parenteral nutrition in patients who tolerate EN and can be fed to the target values.
Consider careful parenteral nutrition in patients intolerant to EN.
Type of formula Whole protein formulae are appropriate in most patients, since peptide-based formulae have not shown clinical 
advantages.
"Immunonutrition":
Glutamine should be added to standard enteral formula in all trauma patients and burn patients.
Formulae enriched with nucleotides and fatty acids are superior to standard enteral formulae in trauma patients, 
patients with ARDS, and patients with mild, but not severe, sepsis (APACHE II score < 15)
Patients with very severe illness who do not tolerate more than 700 ml enteral formulae per day should not 
receive an immune-modulating formula.World Journal of Emergency Surgery 2006, 1:29 http://www.wjes.org/content/1/1/29
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major trauma. Recently published international guide-
lines on enteral nutrition concepts in critically ill patients
are available for implementation in clinical practice and
future prospective studies.
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Denver Health Medical Center institutional protocol for early enteral nutrition of severely injured patients Figure 1
Denver Health Medical Center institutional protocol for early enteral nutrition of severely injured patients. 
Adapted from: [39]. Abbreviations: ABGA, arterial blood gas analysis; ATI, Abdominal Trauma Index; CBC, complete blood 
count; HR, heart rate; ETF, enteral tube feeding; IAP, intraabdominal pressure (bladder pressure); ISS, Injury Severity Score; 
MAR, medicine administration record; NCJ, needle catheter jejunostomy; PEG, percutaneous endoscopic gastrostomy; PRBC, 
packed red blood cells. * Monitoring of IAP for high risk patients with severe pelvic ring injuries, lumbar spine fractures, polytrauma with 
ISS > 17, hemorrhagic shock with > 6 units PRBC in 12 h. ** In massively injured patients (ISS>40, ATI>40, PRBC mass transfusions), 
administer low dose enteral feeding (15–30 ml/h) for the first 3 days due to anticipated intolerance to full-dose enteral feeding. Advance 
per protocol on the 4th day post injury.
Start enteral feeding with: 
15 ml/h x 12h
Monitor for abodminal compartment 
syndrome! (IAP)*
Is ETF tolerated?
Advance 15 ml/h every 12h:
• 30ml/h at 12h
• 45ml/h at 24h
• 60ml/h at 36h 
Diarrhea
Cramping, 
distention
YES
NO
Is ETF tolerated?
Indicator
NO
Monitor every 
shift
YES
High gastric 
residuals 
Severe
• >4x daily
• >600ml
↓
• reduce ETF by 50%
• Review MAR 
• Stool studies 
(C. difficile toxin)
Moderate
• 3-4x daily
• 400-600ml
↓
• Keep ETF rate
• Reassess 
every shift
Mild
• 1-2x daily
• 200-400ml
↓
• Increase ETF 
each schedule
PEG (> 100ml)
• Hold ETF x  6h
• Measure IAP
• Recheck residuals  in 6h
• < 100 ml → restart ETF
NCJ Tube (> 175 ml)
• Hold ETF x  6h
• Measure IAP 
• Check X-ray for post-pyloric      
tube placement
• Recheck residuals in 6 h
• < 175ml → restart ETF
Severe
• Stop ETF
• Measure IAP
• X-ray abdomen 
•G a s t r o g r a f i n
study
•C B C ,  A B G A ,  
lactate
Moderate
• Reduce ETF by 50%
• Measure IAP
• Gastrografin study
↓
Maintain ETF for 12h 
if study is normal, 
then increase
Mild
• Maintain 
ETF
• Repeat 
exam each 6h
If patient improves
Prior to initiating enteral support, the end-points of shock resuscitation must be achieved:
Base excess > -2.5 Meq/L, lactate < 2.5mmol/L, HR < 120/min, no vasopressor or inotropic support
Except for NCJ **World Journal of Emergency Surgery 2006, 1:29 http://www.wjes.org/content/1/1/29
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